1st Faculty of Medicine Charles University 1st Faculty of Medicine Charles University Lymphoma Lab
13.01.2020

Supplemental data to the manuscript by Vockova et al "Anti-CD38 Therapy with Daratumumab for Relapsed/Refractory CD20-Negative Diffuse Large B-Cell Lymphoma Anti-CD38 Therapy with Daratumumab for Relapsed/Refractory CD20-Negative Diffuse Large B-Cell Lymphoma"

 

number of views: 368 last modification: 13.01.2020
Page ranking: If you think the article is not up-to-date, click here.